EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting

Paula Luque Linero, Luis Castilla-Guerra

European Cardiology Review · 09.05.2024 · 19

DOI: 10.15420/ecr.2023.19 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 09.05.2024. Verfasst von Paula Luque Linero und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Risk Unit, Department of Internal Medicine, Hospital Virgen Macarena Seville, Spain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is an overlooked and undetected pathology, which affects more than 32% of adults worldwide. NAFLD is becoming more common in Western industrialised countries, particularly in patients with central obesity, type 2 diabetes, dyslipidaemia and metabolic syndrome. Although NAFLD has traditionally been interpreted as a liver disease with a high risk of liver-related complications, NAFLD is an underappreciated and independent risk factor for atherosclerotic cardiovascular disease, which is the principal cause of death in patients with NAFLD. Treatment options to counteract both the progression and development of cardiovascular disease and NAFLD include lifestyle interventions, such as weight loss, increased physical activity and dietary modification, and optimal medical therapy of comorbid conditions; nevertheless, further studies are needed to define optimal treatment strategies for the prevention of both hepatic and cardiovascular complications of NAFLD.

Schlagwörter

Stichwörter der Autor:innen

NAFLDNASHcardiovascular diseasecardiovascular risk factormetabolic syndrometreatment

Autor:innen und Institutionen

  • Vascular Risk Unit, Department of Internal Medicine, Hospital Virgen Macarena Seville, Spain.
  • Department of Medicine, University of Seville Seville, Spain.

Zitieren

APA

Linero, P. L., & Castilla-Guerra, L. (2024). Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting. European Cardiology Review, 19. https://doi.org/10.15420/ecr.2023.19

Vancouver

Linero PL, Castilla-Guerra L. Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting. European Cardiology Review. 2024;19. doi:10.15420/ecr.2023.19

BibTeX
@article{Linero2024,
  author = {Linero, Paula Luque and Castilla-Guerra, Luis},
  title = {Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting},
  journal = {European Cardiology Review},
  year = {2024},
  volume = {19},
  doi = {10.15420/ecr.2023.19}
}
Kostenlos starten →